HAG
BCLI
HighPoint Advisor Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $45K | Buy |
+17,033
| New | +$45K | ﹤0.01% | 516 |
|
|
2021
Q3 | $56K | Hold |
17,033
| – | – | 0.01% | 542 |
|
|
2021
Q2 | $65K | Buy |
17,033
+1,000
| +6% | +$3.82K | 0.01% | 529 |
|
|
2021
Q1 | $59K | Buy |
16,033
+300
| +2% | +$1.1K | 0.01% | 487 |
|
|
2020
Q4 | $115K | Buy |
15,733
+2,200
| +16% | +$16.1K | 0.01% | 456 |
|
|
2020
Q3 | $149K | Hold |
13,533
| – | – | 0.03% | 357 |
|
|
2020
Q2 | $151K | Hold |
13,533
| – | – | 0.03% | 325 |
|
|
2020
Q1 | $82K | Buy |
+13,533
| New | +$82K | 0.02% | 326 |
|